Salts of guanidine derivatives and pharmaceutical preparations consisting thereof
申请人:——
公开号:US20040192717A1
公开(公告)日:2004-09-30
This invention relates to salts of guanidine derivatives of formula R—X—C(═NH)NH
3
+
Z
−
, wherein X represents a valence bond, —CH
2
—NH—, —CH
2
—NH—NH— or —CH═N—NH—; R represents a linear or branched C
1
-C
30
alkyl, C
3
-C
20
cycloalkyl, adamantyl, norbornyl, tricyclodecyl, benzyl, furyl, pyridyl, anthracyl, naphthyl, phenanthryl, perinaphthyl or quinuclidinyl residue, which can be substituted by one or more hydroxyl groups, C
1
-C
4
alkoxy groups, C
1
-C
4
alkyl groups and/or one or more halogen atoms or one or more amino groups; Z represents O—CO—Y, O—S(O)
2
—Y, or O—P(O)(OH)—Y; and Y represents a linear or branched C
1
-C
12
alkyl, C
3
-C
8
cycloalkyl, benzyl, furyl or pyridyl residue, which can be substituted by one or more hydroxyl groups, carboxylic acid groups, C
1
-C
4
alkoxy groups, C
1
-C
4
alkyl groups and/or one or more halogen atoms or one or more amino groups. These compounds are useful for treating tumor diseases, autoimmune diseases, cardiovascular diseases, infections, and viral diseases.
本发明涉及式 R-X-C(═NH)NH胍衍生物的盐类
3
+
Z
-
其中 X 代表价键、-CH
2
-NH-、-CH
2
-NH-NH-或-CH═N-NH-; R 代表线性或支链 C
1
-C
30
烷基、C
3
-C
20
环烷基、金刚烷基、降冰片烷基、三环癸基、苄基、呋喃基、吡啶基、蒽基、萘基、菲基、周萘基或奎宁基残基,可被一个或多个羟基取代,C
1
-C
4
烷氧基、C
1
-C
4
烷基和/或一个或多个卤素原子或一个或多个氨基; Z 代表 O-CO-Y、O-S(O)
2
-Y,或 O-P(O)(OH)-Y;Y 代表线性或支链 C
1
-C
12
烷基、C
3
-C
8
环烷基、苄基、呋喃基或吡啶基残基,可被一个或多个羟基、羧酸基、 C
1
-C
4
烷氧基、C
1
-C
4
烷基和/或一个或多个卤素原子或一个或多个氨基。这些化合物可用于治疗肿瘤疾病、自身免疫性疾病、心血管疾病、感染和病毒性疾病。